Could a common pill boost biologic therapy for ulcerative colitis?

NCT ID NCT05205603

First seen May 06, 2026 · Last updated May 06, 2026 · Updated 1 time

Summary

This study looked at whether adding mesalazine (a standard anti-inflammatory drug) to biologic treatments like vedolizumab or infliximab can improve healing of the colon lining in people with moderate to severe ulcerative colitis. 438 adults took part. The main goal was to see if more patients achieved endoscopic remission (a healed gut lining) after 12 months with the combination therapy compared to biologics alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EFFICACY, SELF are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • First Affiliated Hospital of Shantou University Medical College

    Shantou, Guangdong, China

  • First People's Hospital of Foshan

    Guangzhou, Guangdong, China

  • General Hospital of Tianjin Medical University

    Tianjin, Tianjin Municipality, China

  • Guangzhou Panyu Central Hospital

    Guangzhou, Guangdong, China

  • Nanhai Hospital, Southern Medical University

    Guangzhou, Guangdong, China

  • People's Hospital of Chongqing

    Chongqing, Chongqing Municipality, China

  • Shengjing Hospital

    Shenyang, Liaoning, China

  • Shunde Hospital of Southern Medical University

    Guangzhou, Guangdong, China

  • The Second Affiliated Hospital of Dalian Medical University

    Dalian, Liaoning, China

  • Zhejiang University

    Hanzhou, Zhejiang, China

  • the Sixth Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, Guangdong, 501655, China

Conditions

Explore the condition pages connected to this study.